Melanoma patients who submit images of lesions to a specialist using a smartphone appear to be a safe and convenient form of follow-up after treatment.
Researchers at the University of Queensland and the University of Sydney have used telephones from 100 patients who helped their partners self-examine their skin and participated in regular follow-up visits by doctors between 2018 and 2020. Evaluated the data.
Professor Monika Janda of the University of Queensland Health Services Research Center said it was patient-led. Surveillance The group detected five new cases of melanoma prior to clinical visits in a randomized pilot study.
“This suggests that the method used was effective in helping this group identify lesions, but the standard treatment group did not identify new melanoma,” Janda said. The professor said.
“Three participants in the new melanoma were found during regular follow-up visits in each group.
“This study also showed that patient reports improved participants’ self-examination knowledge and practice, leading to better psychological results.”
This study, part of the University of Sydney’s MELSELF project, is investigating how smartphone technology can help detect melanoma faster than regular regular follow-up.
Katy Bell, associate professor of public health at the University of Sydney, said patient-led surveillance is a new model of follow-up care. Melanoma patient Use the attachment on your smartphone to send images of skin lesions for quick review by a dermatologist.
“We are currently conducting a larger trial of this same intervention to generate conclusive evidence that patient-led surveillance can detect new melanoma more quickly.”
About 1700 Australians melanoma Each year, another 500 people die of other types of skin cancer.
Professor Janda said that many melanomas can be self-detected if one is trained to systematically self-examine his skin and access timely reviews through patient-led monitoring.
“Regular face-to-face care is resource-intensive and has not been previously tested compared to patient-led surveillance.
“When confirmed in larger studies, this new patient care model eases the burden on clinical visits and healthcare systems and is useful for people, especially those who live far away from treatment centers.”
This study is published at Jama Dermatology..
Deonna M. Ackermann et al, Assessment of the possibility of patient-led monitoring after treatment for localized melanoma (MEL-SELF), Jama Dermatology (2021). DOI: 10.1001 / jamadermatol.2021.4704
University of Queensland
Quote: Patient-led surveillance, melanoma treatment obtained on November 25, 2021 from https: //medicalxpress.com/news/2021-11-patient-led-surveillance-melanoma.html (November 25, 2021) Shows the prospect of (day)
This document is subject to copyright. No part may be reproduced without written permission, except for fair transactions for personal investigation or research purposes. Content is provided for informational purposes only.
Patient-led surveillance shows potential treatment for melanoma
Source link Patient-led surveillance shows potential treatment for melanoma